XML 38 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total Stockholder's Equity
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Deferred Compensation
Noncontrolling Interests
Total
Beginning Balance at Oct. 31, 2022 $ 684,392 $ 41 $ 2,094,076 $ (1,407,973) $ (1,752) $ (855) $ 855 $ 7,105 $ 691,497
Beginning Balance at (in shares) at Oct. 31, 2022   405,562,988              
Common stock issued, non-employee compensation 68   68           68
Common stock issued, non-employee compensation (in shares)   21,106              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (314)   (314)           (314)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   169,065              
Share based compensation 2,637   2,637           2,637
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation 447       447       447
Adjustment for deferred compensation           (68) 68    
Adjustment for deferred compensation (in shares)   (21,106)              
Reclassification of redeemable non-controlling interest               3,030 3,030
Distribution to non-controlling interest               (106) (106)
Net Loss (18,622)     (18,622)       (2,464) (21,086)
Ending Balance at Jan. 31, 2023 667,808 $ 41 2,095,667 (1,426,595) (1,305) (923) 923 7,565 675,373
Ending Balance at (in shares) at Jan. 31, 2023   405,732,053              
Beginning Balance at Oct. 31, 2022 684,392 $ 41 2,094,076 (1,407,973) (1,752) (855) 855 7,105 691,497
Beginning Balance at (in shares) at Oct. 31, 2022   405,562,988              
Effect of foreign currency translation                 132
Net Loss                 (78,598)
Ending Balance at Jul. 31, 2023 699,652 $ 44 2,186,405 (1,485,177) (1,620) (1,026) 1,026 8,342 707,994
Ending Balance at (in shares) at Jul. 31, 2023   444,704,081              
Beginning Balance at Jan. 31, 2023 667,808 $ 41 2,095,667 (1,426,595) (1,305) (923) 923 7,565 675,373
Beginning Balance at (in shares) at Jan. 31, 2023   405,732,053              
Sale of common stock, net of fees 2,663   2,663           2,663
Sale of common stock, net of fees (in shares)   949,438              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   57,222              
Share based compensation 3,194   3,194           3,194
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation (151)       (151)       (151)
Distribution to non-controlling interest               (143) (143)
Net Loss (34,303)     (34,303)       392 (33,911)
Ending Balance at Apr. 30, 2023 638,411 $ 41 2,100,724 (1,460,898) (1,456) (923) 923 7,814 646,225
Ending Balance at (in shares) at Apr. 30, 2023   406,738,713              
Sale of common stock, net of fees 83,271 $ 3 83,268           83,271
Sale of common stock, net of fees (in shares)   37,931,204              
Common stock issued, non-employee compensation 105   105           105
Common stock issued, non-employee compensation (in shares)   42,601              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (58)   (58)           (58)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   34,164              
Share based compensation 3,166   3,166           3,166
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation (164)       (164)       (164)
Adjustment for deferred compensation           (103) 103    
Adjustment for deferred compensation (in shares)   (42,601)              
Distribution to non-controlling interest               (150) (150)
Net Loss (24,279)     (24,279)       678 (23,601)
Ending Balance at Jul. 31, 2023 699,652 $ 44 2,186,405 (1,485,177) (1,620) (1,026) 1,026 8,342 707,994
Ending Balance at (in shares) at Jul. 31, 2023   444,704,081              
Beginning Balance at Oct. 31, 2023 682,493 $ 45 2,199,661 (1,515,541) (1,672) (1,078) 1,078 17,955 $ 700,448
Beginning Balance at (in shares) at Oct. 31, 2023   450,626,862             450,626,862
Common stock issued, non-employee compensation 51   51           $ 51
Common stock issued, non-employee compensation (in shares)   44,398              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (926)   (926)           (926)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   1,235,192              
Share based compensation 2,876   2,876           2,876
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation 33       33       33
Adjustment for deferred compensation           (51) 51    
Adjustment for deferred compensation (in shares)   (44,398)              
Contributions received from sale of noncontrolling interest               25,122 25,122
Distribution to non-controlling interest               (236) (236)
Net Loss (19,793)     (19,793)       (24,606) (44,399)
Ending Balance at Jan. 31, 2024 663,934 $ 45 2,200,862 (1,535,334) (1,639) (1,129) 1,129 18,235 682,169
Ending Balance at (in shares) at Jan. 31, 2024   451,862,054              
Beginning Balance at Oct. 31, 2023 682,493 $ 45 2,199,661 (1,515,541) (1,672) (1,078) 1,078 17,955 $ 700,448
Beginning Balance at (in shares) at Oct. 31, 2023   450,626,862             450,626,862
Effect of foreign currency translation                 $ 96
Net Loss                 (117,178)
Ending Balance at Jul. 31, 2024 675,762 $ 55 2,277,417 (1,600,134) (1,576) (1,198) 1,198 9,345 $ 685,107
Ending Balance at (in shares) at Jul. 31, 2024   553,840,943             553,840,943
Beginning Balance at Jan. 31, 2024 663,934 $ 45 2,200,862 (1,535,334) (1,639) (1,129) 1,129 18,235 $ 682,169
Beginning Balance at (in shares) at Jan. 31, 2024   451,862,054              
Sale of common stock, net of fees 5,893 $ 1 5,892           5,893
Sale of common stock, net of fees (in shares)   6,463,716              
Common stock issued, non-employee compensation 47   47           47
Common stock issued, non-employee compensation (in shares)   46,357              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (52)   (52)           (52)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   68,597              
Share based compensation 3,002   3,002           3,002
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation (78)       (78)       (78)
Adjustment for deferred compensation           (35) 35    
Adjustment for deferred compensation (in shares)   (33,948)              
Distribution to non-controlling interest               (425) (425)
Net Loss (32,140)     (32,140)       (5,516) (37,656)
Ending Balance at Apr. 30, 2024 639,806 $ 46 2,208,951 (1,567,474) (1,717) (1,164) 1,164 12,294 652,100
Ending Balance at (in shares) at Apr. 30, 2024   458,406,776              
Sale of common stock, net of fees 65,848 $ 9 65,839           65,848
Sale of common stock, net of fees (in shares)   95,220,151              
Common stock issued, non-employee compensation 47   47           47
Common stock issued, non-employee compensation (in shares)   70,360              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards 30   30           30
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   195,182              
Share based compensation 3,350   3,350           3,350
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation 141       141       141
Adjustment for deferred compensation           (34) 34    
Adjustment for deferred compensation (in shares)   (51,526)              
Distribution to non-controlling interest               (485) (485)
Net Loss (32,660)     (32,660)       (2,464) (35,123)
Ending Balance at Jul. 31, 2024 $ 675,762 $ 55 $ 2,277,417 $ (1,600,134) $ (1,576) $ (1,198) $ 1,198 $ 9,345 $ 685,107
Ending Balance at (in shares) at Jul. 31, 2024   553,840,943             553,840,943